Literature DB >> 8319892

Long-term survival of Bordetella bronchiseptica in lakewater and in buffered saline without added nutrients.

J F Porter1, A C Wardlaw.   

Abstract

Bordetella bronchiseptica grew from small inocula, and retained viability for at least 24 weeks, in unsupplemented lakewater or phosphate-buffered saline. From washed inocula of around 10(3) colony-forming units/ml, there was growth at both 10 degrees C and 37 degrees C to give 10(6)-10(7) colony-forming units/ml. At 10 degrees C, these counts were maintained with little diminution up to week 24 when observations ceased. In the tests at 37 degrees C, two of three strains tested showed similar retention of viability. These results suggest that B. bronchiseptica may exist as hitherto unsuspected reservoirs of infection in freshwater habitats.

Entities:  

Mesh:

Year:  1993        PMID: 8319892     DOI: 10.1111/j.1574-6968.1993.tb06291.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  12 in total

1.  Expression of the putative siderophore receptor gene bfrZ is controlled by the extracytoplasmic-function sigma factor BupI in Bordetella bronchiseptica.

Authors:  E Pradel; C Locht
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

2.  A highly adherent phenotype associated with virulent Bvg+-phase swine isolates of Bordetella bronchiseptica grown under modulating conditions.

Authors:  K B Register; M R Ackermann
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

3.  Comparison of the genome sequence of the poultry pathogen Bordetella avium with those of B. bronchiseptica, B. pertussis, and B. parapertussis reveals extensive diversity in surface structures associated with host interaction.

Authors:  Mohammed Sebaihia; Andrew Preston; Duncan J Maskell; Holly Kuzmiak; Terry D Connell; Natalie D King; Paul E Orndorff; David M Miyamoto; Nicholas R Thomson; David Harris; Arlette Goble; Angela Lord; Lee Murphy; Michael A Quail; Simon Rutter; Robert Squares; Steven Squares; John Woodward; Julian Parkhill; Louise M Temple
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

Review 4.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Contribution of regulation by the bvg locus to respiratory infection of mice by Bordetella pertussis.

Authors:  T J Merkel; S Stibitz; J M Keith; M Leef; R Shahin
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model.

Authors:  P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.

Authors:  Nathalie Mielcarek; Anne-Sophie Debrie; Dominique Raze; Julie Bertout; Carine Rouanet; Amena Ben Younes; Colette Creusy; Jacquelyn Engle; William E Goldman; Camille Locht
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

8.  Molecular evolution of the two-component system BvgAS involved in virulence regulation in Bordetella.

Authors:  Julien Herrou; Anne-Sophie Debrie; Eve Willery; Geneviève Renauld-Mongénie; Geneviève Renaud-Mongénie; Camille Locht; Frits Mooi; Françoise Jacob-Dubuisson; Rudy Antoine
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

9.  Genomic island excisions in Bordetella petrii.

Authors:  Melanie Lechner; Karin Schmitt; Susanne Bauer; David Hot; Christine Hubans; Erwan Levillain; Camille Locht; Yves Lemoine; Roy Gross
Journal:  BMC Microbiol       Date:  2009-07-18       Impact factor: 3.605

10.  Transcriptome profiling reveals stage-specific production and requirement of flagella during biofilm development in Bordetella bronchiseptica.

Authors:  Tracy L Nicholson; Matt S Conover; Rajendar Deora
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.